April 30, 2024

Cardiovascular Health Supplements Market Size, Share, Report 2033

The global cardiovascular health supplements market size was estimated to be around US$ 11.2 billion in 2023 and is projected to reach US$ 24.07 billion by 2033, indicating a CAGR of 8% from 2024 to 2033.

Cardiovascular Health Supplements Market Size 2024 to 2033

Key Points

  • Asia Pacific dominated the market while contributing 39% market share in 2023.
  • By type, in 2023, the natural supplements segment dominated the market with a 70% market share.
  • By type, the synthetic supplements segment is expected to experience substantial growth at a CAGR of 8.13% during the forecast period.
  • By ingredient, in 2023, the omega fatty acids segment dominated the market with a 31% market share.
  • By ingredient, the herbs & botanicals segment is expected to grow at a CAGR of 10.34 during the forecast period.
  • By form, the softgel segment dominated the market holding the largest share, 37%, in 2023.
  • By form, the capsules segment is expected to grow at a CAGR of 9.95% during the forecast period.
  • By distribution channel, the offline segment held the largest market share of 71% in 2023.
  • By distribution channel, the online segment is observed to grow at a CAGR of 10.42% during the forecast period.

The market research report on the cardiovascular health supplements market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of cardiovascular health supplements products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3790

Cardiovascular Health Supplements Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 8%
Global Market Size in 2023 USD 11.2 Billion
Global Market Size by 2033 USD 24.07 Billion
Largest Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Type, By Form, and By Distribution Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Soybean Market Size to Reach USD 336.28 Billion by 2033

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global cardiovascular health supplements market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the cardiovascular health supplements market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of cardiovascular health supplements products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the cardiovascular health supplements market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the cardiovascular health supplements market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Cardiovascular Health Supplements Market Companies

  • NOW Health Group, Inc.
  • Bright Lifecare Pvt Ltd (Truebasics.com)
  • Natural Organics, Inc.
  • DaVinci Laboratories of Vermont
  • Nordic Naturals
  • Thorne HealthTech, Inc.
  • Nestle (Pure Encapsulations, LLC.)
  • Amway
  • InVite Health
  • GNC Holdings, LLC

Segments Covered in the Report

By Type

  • Natural Supplements
  • Synthetic Supplements
  • Ingredient Outlook (Revenue, USD Million, 2018 – 2030)
  • Vitamins & Minerals
  • Herbs & Botanicals
  • Omega Fatty Acids
  • Coenzyme Q10 (CoQ10)
  • Others

By Form

  • Liquid
  • Tablet
  • Capsules
  • Softgels
  • Powder
  • Others

By Distribution Channel 

  • Offline
  • Online

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiovascular Health Supplements Market 

5.1. COVID-19 Landscape: Cardiovascular Health Supplements Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiovascular Health Supplements Market, By Type

8.1. Cardiovascular Health Supplements Market Revenue and Volume, by Type, 2024-2033

8.1.1 Natural Supplements

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Synthetic Supplements

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Ingredient Outlook (Revenue, USD Million, 2018 – 2030)

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Vitamins & Minerals

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Herbs & Botanicals

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Omega Fatty Acids

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Coenzyme Q10 (CoQ10)

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Others

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Cardiovascular Health Supplements Market, By Form

9.1. Cardiovascular Health Supplements Market Revenue and Volume, by Form, 2024-2033

9.1.1. Liquid

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Tablet

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Capsules

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Softgels

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Powder

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Cardiovascular Health Supplements Market, By Distribution Channel 

10.1. Cardiovascular Health Supplements Market Revenue and Volume, by Distribution Channel, 2024-2033

10.1.1. Offline

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Online

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Cardiovascular Health Supplements Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 12. Company Profiles

12.1. NOW Health Group, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Bright Lifecare Pvt Ltd (Truebasics.com)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Natural Organics, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DaVinci Laboratories of Vermont

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nordic Naturals

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Thorne HealthTech, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Nestle (Pure Encapsulations, LLC.)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Amway

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. InVite Health

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GNC Holdings, LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *